DOMH
Price
$3.53
Change
-$0.39 (-9.95%)
Updated
Apr 3 closing price
Capitalization
50.38M
40 days until earnings call
MBRX
Price
$0.87
Change
-$0.09 (-9.38%)
Updated
Apr 3 closing price
Capitalization
11.56M
Ad is loading...

DOMH vs MBRX

Header iconDOMH vs MBRX Comparison
Open Charts DOMH vs MBRXBanner chart's image
Dominari Holdings
Price$3.53
Change-$0.39 (-9.95%)
Volume$294.49K
Capitalization50.38M
Moleculin Biotech
Price$0.87
Change-$0.09 (-9.38%)
Volume$336.88K
Capitalization11.56M
DOMH vs MBRX Comparison Chart
Loading...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOMH vs. MBRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOMH is a Hold and MBRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DOMH: $3.50 vs. MBRX: $0.87)
Brand notoriety: DOMH and MBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOMH: 13% vs. MBRX: 4%
Market capitalization -- DOMH: $50.38M vs. MBRX: $11.56M
DOMH [@Biotechnology] is valued at $50.38M. MBRX’s [@Biotechnology] market capitalization is $11.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOMH’s FA Score shows that 1 FA rating(s) are green whileMBRX’s FA Score has 0 green FA rating(s).

  • DOMH’s FA Score: 1 green, 4 red.
  • MBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, DOMH is a better buy in the long-term than MBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOMH’s TA Score shows that 2 TA indicator(s) are bullish while MBRX’s TA Score has 2 bullish TA indicator(s).

  • DOMH’s TA Score: 2 bullish, 6 bearish.
  • MBRX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, MBRX is a better buy in the short-term than DOMH.

Price Growth

DOMH (@Biotechnology) experienced а -33.08% price change this week, while MBRX (@Biotechnology) price change was -17.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

DOMH is expected to report earnings on May 14, 2025.

MBRX is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DOMH($50.4M) has a higher market cap than MBRX($11.6M). DOMH YTD gains are higher at: 273.156 vs. MBRX (-48.900). DOMH has higher annual earnings (EBITDA): -14.1M vs. MBRX (-28.79M). DOMH has more cash in the bank: 49.7M vs. MBRX (9.41M). MBRX has less debt than DOMH: MBRX (506K) vs DOMH (3.15M). DOMH has higher revenues than MBRX: DOMH (12.6M) vs MBRX (0).
DOMHMBRXDOMH / MBRX
Capitalization50.4M11.6M434%
EBITDA-14.1M-28.79M49%
Gain YTD273.156-48.900-559%
P/E RatioN/AN/A-
Revenue12.6M0-
Total Cash49.7M9.41M528%
Total Debt3.15M506K623%
FUNDAMENTALS RATINGS
DOMH vs MBRX: Fundamental Ratings
DOMH
MBRX
OUTLOOK RATING
1..100
7782
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
3494
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DOMH's Valuation (29) in the null industry is in the same range as MBRX (36) in the Pharmaceuticals Major industry. This means that DOMH’s stock grew similarly to MBRX’s over the last 12 months.

DOMH's Profit vs Risk Rating (100) in the null industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that DOMH’s stock grew similarly to MBRX’s over the last 12 months.

DOMH's SMR Rating (97) in the null industry is in the same range as MBRX (99) in the Pharmaceuticals Major industry. This means that DOMH’s stock grew similarly to MBRX’s over the last 12 months.

DOMH's Price Growth Rating (34) in the null industry is somewhat better than the same rating for MBRX (94) in the Pharmaceuticals Major industry. This means that DOMH’s stock grew somewhat faster than MBRX’s over the last 12 months.

DOMH's P/E Growth Rating (100) in the null industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that DOMH’s stock grew similarly to MBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DOMHMBRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Bullish Trend 24 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSK39.011.37
+3.64%
GSK plc
ICCC5.38-0.04
-0.74%
ImmuCell Corp
NTCT20.18-1.39
-6.44%
NetScout Systems
MREO2.21-0.16
-6.75%
Mereo BioPharma Group plc
GXO36.30-3.81
-9.50%
GXO Logistics

DOMH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DOMH has been loosely correlated with EDSA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if DOMH jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOMH
1D Price
Change %
DOMH100%
-9.95%
EDSA - DOMH
36%
Loosely correlated
-5.31%
AXON - DOMH
36%
Loosely correlated
-3.35%
MBRX - DOMH
31%
Poorly correlated
-9.60%
ARDX - DOMH
31%
Poorly correlated
-2.87%
FHTX - DOMH
30%
Poorly correlated
-7.89%
More

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with EDSA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-9.60%
EDSA - MBRX
36%
Loosely correlated
-5.31%
AMRN - MBRX
32%
Poorly correlated
-2.18%
DOMH - MBRX
30%
Poorly correlated
-9.95%
AXON - MBRX
29%
Poorly correlated
-3.35%
VKTX - MBRX
29%
Poorly correlated
-5.69%
More